EUVIMEDEUVIMED entdecken
Crossref

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume

Elizabeth Robinson iD, Netty Kinsella, Derfel Ap Dafydd, Joshua Shur, Aslam Sohaib, Steve Hazell, Paul Bassett, Pardeep Kumar, Erik Mayer, Declan Cahill, Samuel J Withey

The Prostate · 2025-06 · 85 (8) · 784-791

DOI: 10.1002/pros.24886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, online erschienen am 03.03.2025. Verfasst von Elizabeth Robinson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostate-Specific Antigen, Prostate. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: This work was supported by the National Institute for Health Research (NIHR) Royal Marsden Biomedical Research Centre (BRC, Ref. NIHR203314) and NIHR Imperial….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate specific antigen density (PSAd) is one of the strongest predictors of clinically‐significant prostate cancer (csPCa) in risk calculators. There is little evidence on the effect of prostate volume on the diagnostic performance of PSAd. Our aim was to define the diagnostic accuracy of PSAd for predicting csPCa across prostate volumes.

Methods

548 patients who underwent magnetic resonance imaging (MRI) and biopsy were included in this retrospective study. Patients were grouped by prostate volume; small (≤ 30 mL), medium (> 30 to < 50 mL), large (≥ 50 mL). Sensitivity and specificity of PSAd were assessed at thresholds of ≥ 0.10, ≥ 0.15, and ≥ 0.20 ng/mL/mL for two definitions of csPCa.

Results

At all PSAd thresholds and for both definitions of csPCa, there was a statistically significant and clinically‐relevant difference in diagnostic performance across prostate volume groups. Sensitivity was highest in small glands, lowest in large glands; the opposite being true for specificity. Using a PSAd threshold of ≥ 0.15 ng/mL/mL, sensitivity for ISUP grade ≥ 2 PCa was 83.1%, 63.6%, and 33.3% for small, medium and large prostates ( p ≤ 0.001) with specificities of 48.5%, 67.5% and 79.3%, respectively ( p = 0.005).

Conclusions

Diagnostic performance of PSAd varied significantly by prostate volume, and by applying a single PSAd threshold across all prostate volumes risks missing csPCa in men with larger glands, whilst performing unnecessary biopsies in those with smaller glands. Defining PSAd thresholds according to prostate volume categories can therefore improve its use as a risk predictor for csPCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstate-Specific AntigenProstateHumansMaleRetrospective StudiesMiddle AgedAgedMagnetic Resonance ImagingOrgan SizeSensitivity and SpecificityBiopsy

Stichwörter der Autor:innen

PSA densityadenocarcinomadiagnostic accuracyprostateprostate specific antigenprostate volume

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK.
  • Department of Urology, Royal Marsden NHS Foundation Trust, London, UK.
  • Department of Pathology, Royal Marsden NHS Foundation Trust, London, UK.
  • Statsconsultancy Limited, Amersham, UK.
  • Department of Surgery & Cancer, Imperial College London, London, UK.
  • iCARE Secure Data Environment, NIHR Imperial BRC, London, UK.

ORCID-Profile: Elizabeth Robinson

Förderung

  • This work was supported by the National Institute for Health Research (NIHR) Royal Marsden Biomedical Research Centre (BRC, Ref. NIHR203314) and NIHR Imperial…

Zitieren

APA

Robinson, E., Kinsella, N., Ap Dafydd, D., Shur, J., Sohaib, A., Hazell, S., Bassett, P., Kumar, P., Mayer, E., Cahill, D., & Withey, S. J. (2025). Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume. The Prostate, 85(8), 784-791. https://doi.org/10.1002/pros.24886

Vancouver

Robinson E, Kinsella N, Ap Dafydd D, Shur J, Sohaib A, Hazell S, et al. Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume. The Prostate. 2025;85(8):784-791. doi:10.1002/pros.24886

BibTeX
@article{Robinson2025,
  author = {Robinson, Elizabeth and Kinsella, Netty and Ap Dafydd, Derfel and Shur, Joshua and Sohaib, Aslam and Hazell, Steve and Bassett, Paul and Kumar, Pardeep and Mayer, Erik and Cahill, Declan and Withey, Samuel J},
  title = {Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume},
  journal = {The Prostate},
  year = {2025},
  volume = {85},
  number = {8},
  pages = {784--791},
  doi = {10.1002/pros.24886}
}
Kostenlos starten →